细胞培养 >> 细胞
NCI-N87 [N87]人胃癌细?2013年新引进)
产品介绍
| 目录叶br/>Serial |
SCSP-534 |
| 标识?br/>Identifier |
CSTR:19375.09.3101HUMSCSP534 |
描述 Description |
该细胞表面表达糖蛋白癌胚抗原(CEA)和TAG 72,左旋多巴脱羧酶(DDC)表达阴性。血管活性的肠肽(VIP)受体活性极低并缺乏胃泌激素受体。该细胞表达蕈毒碱胆碱受?muscarinic cholinergic agents),但没有证据表明表达N-myc、L-myc、myb EGFR基因。该细胞表达的c-myc和c-erb-B 2 mRNA水平与其它细胞株相似,但不表达N-myc、L-myc、c-cis、IGF-2和胃泌激素释放肽(gastrin releasing peptide)。有报道认为NCI-N87细胞的植板率?.3%。每个批次均通过本库支原体检测,结果为阴性。经本库STR检测结果无误。STR结果如下:Amelogenin: X,Y;CSF1PO: 8,12;D13S317: 8,11;D16S539: 9,13;D5S818: 12,13;D7S820: 10,11;THO1: 9;TPOX: 9,11;vWA: 15,16 |
动物种别 Organism |
亹/span> |
性别 Gender |
甶/span> |
组织来源 Tissue and Cell Type |
胃;分离自转移灶:肝脎/span> |
| 形?br/>Morphology |
上皮样,贴壁生长 |
| 培养基和添加剁br/>Complete Growth Medium and Culture Conditions |
人胃癌细胞NCI-N87完全培养液配?100 ml)9br/> RPMI 1640 Medium (Invitrogen, 11875-093) 88 ml FBS (Gibco) 10 ml Glutamax(invitrogen 35050) 1 ml Sodium Pyruvate 100 mM Solution (invitrogen 11360070) 1 ml 气相:空气,95%;二氧化碳,5%。温度:37摄氏度、br/>注意事项9br/>该细胞贴壁较慢,且生长缓慢,建议复苏、传代后让细胞贴?8h后再进行后续实验操作。细胞最初将附着形成小岛状,然后在这些密集的斑块中增殖,因此很难正确估计汇合度。避免细胞过密生长,及时更换新鲜培养基,以免培养基的pH受到不利影响。该细胞培养时,在培养基中会有一些漂浮细胞和碎片,并且在该细胞中可能会观察到较大的“囊泡”和颗粒状外观,是正常现象、/span> |
供应限制 Permits and Restrictions |
A。仅供研究之用、/span> |
| REFERENCE |
Park JG, et al. Characteristics of cell lines established from human gastric carcinoma. Cancer Res. 50: 2773-2780, 1990. PubMed: 2158397 NCI-Navy Medical Oncology Branch Cell Line Supplement. J. Cell. Biochem. suppl. 24: 1996. NCI-N87 is a gastric carcinoma cell line derived in 1976 by A. Gazdar and associates at the National Cancer Institute from a liver metastasis of a well differentiated carcinoma of the stomach taken prior to cytotoxic therapy. The tumor was passaged as a xenograft in athymic nude mice for three passages before the cell line was established. |
|
|
相关产品
|